Biggest News Aggregation in the World
📰 Rom News

Page 554 - Rom News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Rom. Real-time updates on events, politics, business and more.

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Celcuity Inc.: Celcuity Presents Updated Results from Phase 1b Study of Gedatolisib in Treatment-Naïve Patients at the 2023 ESMO Breast Cancer Annual Congress

Median progression free survival (PFS) was 48.6 months in treatment-naïve patients with HR+/HER2- advanced breast cancer who were treated with gedatolisib in combination with palbociclib and letrozoleMedian
San Antonio United States Vicky Hahne Robert Uhl Brian Sullivan Igor Gorbatchevsky

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science